Altasciences completes acquisition of US-based CRO WCCT Global
Mid-size CRO/CDMO Altasciences has acquired early-stage clinical research organisation (CRO) WCCT Global. WCCT is located in southern California on the…
Latest Deals
Investment firm GI Partners closes Clinical Ink acquisition
Private equity investment firm GI Partners has announced the completion of the acquisition of global clinical trial technology firm Clinical…
Latest News
View More
Ireland’s ICON signs agreement to acquire PRA Health Sciences
Irish company ICON has agreed to acquire contract research company PRA Health Sciences in a cash and stock deal valued at about $12bn. The acquisition…
Stealth BioTherapeutics concludes enrolment in Phase II AMD study
Stealth BioTherapeutics has completed enrolment in the Phase II ReCLAIM-2 study (SPIAM-202) of its lead product candidate, elamipretide, in patients with dry age-related macular degeneration…
NeuroRx’s Zyesami accelerates recovery in Covid-19 trial
NeuroRx has reported that the Phase IIb/III trial of Zyesami (aviptadil, previously RLF-100) showed multidimensional benefit in treating respiratory failure…
Yale announces new trial to reduce Covid-19 complications with new therapy combo
Yale School of Medicine has announced a randomised clinical trial led by the Yale Cardiovascular Research Group (YCRG) to study…
RedHill Biopharma to expand Covid-19 trial of opaganib to US
Specialty biopharmaceutical company RedHill Biopharma is set to expand its global Phase II/III study of opaganib in patients with severe…
Adamis to commence Phase II/III study of Covid-19 therapy
Speciality biopharmaceutical company Adamis Pharmaceuticals is set to proceed with the Phase II/III study of Tempol (MBM-02) for treating Covid-19.…
Company A-Z
View More
VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
Latest Content
View MoreUKONIQ™ (umbralisib) for the Treatment of Marginal Zone Lymphoma (MZL) and Follicular Lymphoma (FL)
UKONIQ™ (umbralisib) is the first and only oral, dual inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
New Warehouse Construction at Staufen Headquarters
In the past few months, two new warehouses were erected and put into operation on the IKA premises. IKA continues…
The Complete Guide to Freelancers in MedTech
The global MedTech outsourcing market has ballooned as businesses look for ways to improve patient care while streamlining their own…